Lantern Pharma Inc
Biotechnology
Healthcare
LTRN
10.78 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.17
52 week high
5.40
high
4.24
52 week low
0.00
previous Close
4.16
P/E ratio
market cap
56.08 M
div yield
0
net profit margin
0.00 %
4507.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top